Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CRISPR Therapeutics AG (CRSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/14/2023 3 Prasad Raju (CFO) has filed a Form 3 on CRISPR Therapeutics AG
06/10/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/23/2022 3 Morrow Phuong Khanh (Chief Medical Officer) has filed a Form 3 on CRISPR Therapeutics AG
10/15/2021 3 Smith Brendan (CFO) has filed a Form 3 on CRISPR Therapeutics AG
06/14/2021 3 Fleming Harold Edward (Director) has filed a Form 3 on CRISPR Therapeutics AG
06/15/2020 3 Treco Douglas A (Director) has filed a Form 3 on CRISPR Therapeutics AG
06/13/2019 3 High Katherine A (Director) has filed a Form 3 on CRISPR Therapeutics AG
06/13/2019 3 Greene John (Director) has filed a Form 3 on CRISPR Therapeutics AG
01/03/2019 3 Klein Lawrence Otto (Chief Business Officer) has filed a Form 3 on CRISPR Therapeutics AG
12/21/2018 3 Vertex Pharmaceuticals (Europe) Ltd (10% Owner) has filed a Form 3 on CRISPR Therapeutics AG
11/13/2017 3 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 3 on CRISPR Therapeutics AG
08/01/2017 3 Ho Tony W (See Remarks) has filed a Form 3 on CRISPR Therapeutics AG
06/01/2017 3 KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Form 3 - Initial statement of beneficial ownership of securities
10/18/2016 3 GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Hadley Harbor Master Investors (Cayman) L.P. (10% Owner) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Form 3 - Initial statement of beneficial ownership of securities
10/18/2016 3 Behbahani Ali (Director) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Versant Venture Capital IV, L.P. (10% Owner) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Dylan-Hyde Tyler (Chief Legal Officer) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Lundberg Sven Ante (Chief Scientific Officer) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 COLES N ANTHONY (Director) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Woiwode Thomas (Director) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 BECKER MARC (CFO) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 George Simeon (Director) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 EMSTER KURT VON (Director) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Kulkarni Samarth (Chief Business Officer) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Subramanian Kala (See Remarks) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Novak Rodger (CEO) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 CAGNONI PABLO J (Director) has filed a Form 3 on CRISPR Therapeutics AG
10/18/2016 3 Bolzon Bradley J PhD (Director) has filed a Form 3 on CRISPR Therapeutics AG

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy